[GetPortalCommentsPageByObjectIdResponse(id=2183647, encodeId=16c2218364ee1, content=#黄芩苷#通过激活胰岛素信号通路、抑制#氧化应激#和AGEs的产生来缓解#胰岛素抵抗#，具有改善#糖尿病#伴#肥胖#前期的肝胰岛素和糖脂代谢紊乱的药物开发潜力。, beContent=null, objectType=article, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63972, encryptionId=0410639e2b0, topicName=氧化应激), TopicDto(id=76652, encryptionId=4f77e665253, topicName=糖尿病), TopicDto(id=81891, encryptionId=3ad9818917c, topicName=肥胖), TopicDto(id=83882, encryptionId=a7cc8388290, topicName=胰岛素抵抗), TopicDto(id=103195, encryptionId=daab103195b7, topicName=黄芩苷)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Wed Jan 24 11:49:10 CST 2024, time=2024-01-24, status=1, ipAttribution=加利福尼亚), GetPortalCommentsPageByObjectIdResponse(id=2183642, encodeId=bb372183642d9, content=#黄芩苷#, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103195, encryptionId=daab103195b7, topicName=黄芩苷)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cade5395722, createdName=梅斯管理员, createdTime=Wed Jan 24 11:25:18 CST 2024, time=2024-01-24, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2183653, encodeId=7ea3218365368, content=签到学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211111/81c0b64745c644319545ec26d7ef0b34/9ddb2864d5df4dd9bf4305e380bffc96.jpg, createdBy=c7835705079, createdName=屋顶瞄爱赏月, createdTime=Wed Jan 24 12:08:30 CST 2024, time=2024-01-24, status=1, ipAttribution=贵州省)]
2024-01-24
屋顶瞄爱赏月
来自贵州省
签到学习
100
0
举报